Promius Pharma, LLC

Quick facts

Marketed products

• Cloderm Cream · Dermatology
  Cloderm Cream is a topical corticosteroid that reduces inflammation and suppresses immune responses in the skin.
• Desonide Cream 0.05%

Phase 3 pipeline

• DFD06 Cream · Dermatology
  DFD06 is a topical corticosteroid cream that reduces inflammation and immune-mediated skin responses by suppressing inflammatory cytokines and T-cell activation in dermatological conditions.

Phase 2 pipeline

• ACT01 · Multiple Sclerosis
  ACT01 is a small molecule that targets the S1P receptor.
• Comp01
  The mechanism of action for Comp01 is currently under investigation and not fully characterized.
• Comp02
• Comp03 · Multiple sclerosis
  Comp03 is a small molecule that targets the S1P receptor.
• Comp04 · Diabetes
  Comp04 is a selective and potent inhibitor of the sodium-glucose cotransporter 2 (SGLT2).
• DFD-07 Cream

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Promius Pharma, LLC portfolio CI brief
• Promius Pharma, LLC pipeline updates RSS